Cargando…
SP1 promotes tumor angiogenesis and invasion by activating VEGF expression in an acquired trastuzumab-resistant ovarian cancer model
Ovarian cancer is one of the most common gynecologic cancers and the leading cause of mortality in women worldwide. HER2/neu is overexpressed in various types of cancers and is most commonly associated with decreased survival. Trastuzumab is a humanized anti-HER2 monoclonal antibody for the treatmen...
Autores principales: | Su, Feng, Geng, Jing, Li, Xinying, Qiao, Chuan, Luo, Longlong, Feng, Jiannan, Dong, Xinjun, Lv, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780020/ https://www.ncbi.nlm.nih.gov/pubmed/29048687 http://dx.doi.org/10.3892/or.2017.5998 |
Ejemplares similares
-
Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3
por: Wang, Wei, et al.
Publicado: (2014) -
Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling
por: Liu, Yang, et al.
Publicado: (2016) -
FBXW7 inhibits invasion, migration and angiogenesis in ovarian cancer cells by suppressing VEGF expression through inactivation of β-catenin signaling
por: Zhong, Liping, et al.
Publicado: (2021) -
hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor
por: Liu, Ning, et al.
Publicado: (2016) -
EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells
por: Niu, Xuping, et al.
Publicado: (2023)